Showing 3581-3590 of 6035 results for "".
- Oculus Supports IMI in Raising Myopia Awarenesshttps://modernod.com/news/oculus-supports-imi-in-raising-myopia-awareness/2479430/Oculus has joined the International Myopia Institute (IMI) in tackling myopia awareness and will support the IMI activities to advance the research of myopia to prevent future vision impairment and blindness. “We are delighted about the cooperation. Our mission at Oculus is to support eye
- United Nations Resolution Designed to Tackle Preventable Sight Losshttps://modernod.com/news/united-nations-resolution-designed-to-tackle-preventable-sight-loss/2479406/The United Nations General Assembly (UNGA) has adopted
- Scientists Discover Gene Therapy Provides Neuroprotection to Prevent Glaucoma Vision Losshttps://modernod.com/news/scientists-discover-gene-therapy-provides-neuroprotection-to-prevent-glaucoma-vision-loss/2479407/A form of gene therapy protects optic nerve cells and preserves vision in mouse models of glaucoma, according to research supported by NIH’s National Eye Institute. The findings suggest a way forward for developing neuroprotective therapies for glaucoma, a leading cause of visual impairment and b
- Alcon Reinforces Strength of Ophthalmology Portfolio With Surgical Device Scientific Presence at ASCRShttps://modernod.com/news/alcon-reinforces-strength-of-ophthalmology-portfolio-with-surgical-device-scientific-presence-at-ascrs/2479398/Alcon will present a breadth of data during the American Society of Cataract and Refractive Surgery (ASCRS) 2021 annual meeting, taking place July 23-27 in Las Vegas. More than 60 abstracts featuring Alcon ophthalmic products and equipment will be presented. The full abstract book, registration l
- Monty Montoya Appointed CEO of TherOptixhttps://modernod.com/news/monty-montoya-appointed-ceo-of-theroptix/2479395/Monty Montoya has been named chief executive officer of TherOptix, a preclinical biopharma company focused on delivering clinically impactful therapeutics via a drug-eluting contact lens platform. TherOptix has received orphan drug designation on its lead candidate (001) for prevention of prolife
- Alcon to Share New Data and Live Booth Presentations at ASCRShttps://modernod.com/news/alcon-to-share-new-data-and-live-booth-presentations-at-ascrs/2479391/Alcon will have approximately 70 abstracts highlighting the benefits of the Alcon Cataract and Refractive suite. A few highlights of the Alcon data include: Robust data demonstrates extremely high level of patient satisfaction and increased spectacle independence for market-leading <
- Eyenuk Announces $6.2 Million Financing to Accelerate Adoption of FDA-Cleared AI Technology for Detection of Diabetic Retinopathyhttps://modernod.com/news/eyenuk-announces-6-2-million-financing-to-accelerate-adoption-of-fda-cleared-ai-technology-for-detection-of-diabetic-retinopathy/2479388/Eyenuk announced that it has completed a financing round of $6.2 million to accelerate commercialization of the EyeArt AI System, which received FDA clearance in 2020 and is being reimbursed by Medicare and other payo
- Johnson & Johnson Vision to Present Scientific Data Validating Improved Surgical Outcomes and Legacy MGD Treatment at ASCRShttps://modernod.com/news/johnson-johnson-vision-to-present-scientific-data-validating-improved-surgical-outcomes-and-legacy-mgd-treatment-at-ascrs/2479387/Johnson & Johnson Vision announced that 21 company-sponsored studies supporting cataract surgery outcomes will be presented at the 2021 American Society of Cataract and Refractive Surgery (ASCRS) and American Society of Ophthalmic Administrators (ASOA) Annual Meeting in Las Vegas Nevada, July
- FDA Sets January Deadline to Decide on Full Approval of Pfizer, BioNTech Vaccinehttps://modernod.com/news/fda-sets-january-deadline-to-decide-on-full-approval-of-pfizer-biontech-vaccine/2479380/Pfizer and BioNTech said that the FDA has granted a priority review for an application seeking full approval of their vaccine BNT162b2 to prevent COVID-19 in people 16 years and older, according to a FirstWord
- Heru Bolsters Executive Team with Seasoned Industry Veteranshttps://modernod.com/news/heru-bolsters-executive-team-with-seasoned-industry-veterans/2479373/Heru, a developer of wearable AI-powered vision diagnostics and augmentation software, has expanded its executive leadership team with the appointment of several strategic hires. Joining Heru are Mary Durbin, PhD, as Chief Scientific Officer; Bob George as Chief Technology Officer; Corey Nielson